Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 55 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2012Current decision rules in fetal surveillance are suboptimalKaandorp, J.; Mesker, A.; Loix, S.; de Boer, F.; Kentson, E.; Kleppe, M.; Baalman, J.; Schuit, E.; Benders, M.; Visser, G.; Derks, J.; Mol, B.; 59th Annual Scientific Meeting (22 Mar 2012 - 24 Mar 2012
2017A revised prediction model for natural conceptionBensdorp, A.; van der Steeg, J.; Steures, P.; Habbema, J.; Hompes, P.; Bossuyt, P.; van der Veen, F.; Mol, B.; Eijkemans, M.
2018Assisted reproductive technology in Beijing, 2013–2015Zhou, Z.; Chen, L.; Wu, H.; Zheng, D.; Li, R.; Mol, B.; Qiao, J.
2013Cardiovascular risk factors in women who had hypertensive disorders late in pregnancy: a cohort studyHermes, W.; Franx, A.; van Pampus, M.; Bloemenkamp, K.; Bots, M.; van der Post, J.; Porath, M.; Ponjee, G.; Tamsma, J.; Mol, B.; de Groot, C.
2011Couples with unexplained subfertility and unfavorable prognosis: a randomized pilot trial comparing the effectiveness of in vitro fertilization with elective single embryo transfer versus intrauterine insemination with controlled ovarian stimulationCusters, I.; Konig, T.; Broekmans, F.; Hompes, P.; Kaaijk, E.; Oosterhuis, G.; Mochtar, M.; Repping, S.; van Wely, M.; Steures, P.; van der Veen, F.; Mol, B.
2014How are neonatal and maternal outcomes reported in randomised controlled trials (RCTs) in reproductive medicine?Braakhekke, M.; Kamphuis, E.; Van Rumste, M.; Mol, F.; Van Der Veen, F.; Mol, B.
201117-alpha-hydroxyprogesterone caproate for the prevention of adverse neonatal outcome in multiple pregnancies: A randomized controlled trialLim, A.; Schuit, E.; Bloemenkamp, K.; Bernardus, R.; Duvekot, J.; Erwich, J.; van Eyck, J.; Groenwold, R.; Hasaart, T.; Hummel, P.; Kars, M.; Kwee, A.; van Oirschot, C.; van Pampus, M.; Papatsonis, D.; Porath, M.; Spaanderman, M.; Willekes, C.; Wilpshaar, J.; Mol, B.; et al.
2015Should the individual preterm birth risk be incorporated into the embryo transfer policy in in vitro fertilisation? A decision analysisKamphuis, E.; Van Wely, M.; Repping, S.; Van Der Veen, F.; De Groot, C.; Hompes, P.; Mol, B.; Kazemier, B.
2013The M-OVIN study: does switching treatment to FSH and / or IUI lead to higher pregnancy rates in a subset of women with world health organization type II anovulation not conceiving after six ovulatory cycles with clomiphene citrate - a randomised controlled trialNahuis, M.; Weiss, N.; van der Veen, F.; Mol, B.; Hompes, P.; Oosterhuis, G.; Lambalk, C.; Smeenk, J.; Koks, C.; van Golde, R.; Laven, J.; Cohlen, B.; Fleischer, K.; Goverde, A.; Gerards, M.; Klijn, N.; Nekrui, L.; van Rooij, I.; Hoozemans, D.; van Wely, M.
2011Prognostic model for survival in patients with early stage cervical cancerBiewenga, P.; van der Velden, J.; Mol, B.; Stalpers, L.; Schilthuis, M.; van der Steeg, J.; Burger, M.; Buist, M.